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urrent  status  of  robotic  rectal  cancer  surgerystado  atual  da  cirurgia  robótica  no  câncer  do  retonthusiasm for the robotic platform, as a minimally invasive
pproach,  has gained most interest in many  surgical spe-
ialities  and today almost two million operations have been
erformed  in the world with the da Vinci Surgical System. The
afety  and efﬁcacy of robotic surgery have been established
or  certain operations, most notably radical prostatectomy. All
olorectal operations have been performed safely in a robotic
ashion;  however, the data on clinical and economic beneﬁts
erived  from controlled trials have not yet totally supported its
ffectiveness, even in robotic rectal cancer surgery. It is essen-
ial  that a proper assessment of this new and sophisticated
echnology be performed before its widespread recommenda-
ion.
Recent studies have reported better short-term outcomes
nd  similar oncological result when comparing laparoscopic
ectal cancer surgery to open surgery. Nevertheless, laparo-
copic  rectal surgery could not achieve a high impact, mainly,
ecause  of the steep learning curve, high rate of conversion,
nd  the technical challenge of work in a narrow pelvis with
imited  instruments maneuverability, especially in obese and
n  patients who  were  treated by preoperative chemo-radiation.
Robotic rectal resection represents the main indication
f  the use of the robotic technique in colorectal surgery.
he  feasibility of robotics for TME  rectal cancer resection
as  established by Pigazzi et al.1 in 2006. Robotic rectal
urgery offers various advantages over traditional laparoscopy
ecause  it can provide surgeons with a three-dimension mag-
iﬁcation  (3DHD) view and the ability to control the operative
eld  by manipulating the camera, as well as enhanced dex-
erity  and precision due to endo-wrist instruments with 7
egrees  of freedom. The robotic system improves visualiza-
ion,  exposure, and dissection in conﬁned spaces such as the
elvic  cavity. Additionally, in the robotic platform the sur-
eon  is ambidextrous and can operate the console comfortably
eated  with excellent ergonomics. Appropriate training and
ractice  on robotic systems and the use of simulator with
raining  software are helpful in gaining familiarity with theskills  required for successful robotic surgery, as well as to facil-
itate  the requirements for the ﬁnal credentialing approved by
the proctor.
Not only lower rates of conversion of robotic surgery when
compared with laparoscopic ones in rectal resections were
reported2 but also a markedly shorter learning curve and a
smaller  number of patients for the surgeon to become proﬁ-
cient  at robotic colorectal surgery, even for surgeon with less
expert  in laparoscopy.3,4 This can be an important beneﬁt as
the  conversion is directly related to a higher rate of post-
operative complications and mortality as have showed the
CLASICC  trial.5 The robotic surgery improves the quality of
mesorectal  excision and provides greater number of surgical
specimens  with a degree of complete excision and negative
circumferential resection margin,6 which is related to lower
local  recurrence. The preservation of the pelvic plexus nerves
is  also superior and, consequently, urinary and sexual func-
tion  are better.7,8 Additionally, in ultralow anterior resection,
the  incidence of anastomotic ﬁstula is lower in the robotic
group.9 Little medical literature exists directly addressing the
costs  of robotic rectal cancer surgery; certainly, robotic surgery
is  more  expensive, but future advances in robotic technology
and  competition in the marketplace will help to reduce the
cost  in the next years.
Currently,  standardized robotic rectal surgery is a promis-
ing  and new alternative and may  provide a powerful additional
tool  for optimal management of this complex disease. Data
suggest  that it is feasible and safe and have same advan-
tages  over laparoscopic surgery, although it has not clearly
established a huge beneﬁt over standard laparoscopic surgery
in  terms of technical, functional or oncological outcomes in
large  randomized trials. It is therefore of utmost importance
that  a good evaluation be made before the widespread use
of  robotics in rectal cancer surgery. It is very important to
know  its impact on oncological outcomes, its effect on func-
tional  outcomes and QoL, and its cost–effectiveness in terms
of  future healthcare decision-making. Those information are
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the objectives of the randomized controlled trial (Robotic ver-
sus Laparoscopic resection for rectal cancer – ROLARR)10 that
have  the anticipated end date in 9/30/2014 after 400 patients’
evaluation. There is a great interest of the colorectal and onco-
logic  community to know those results and especially, the level
of  evidence and the grade of recommendation of this tech-
nique.  This study, certainly, will provide important decision
orientation to justify the future implementation of this option
to  treat patients with rectal cancer around the world.
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